Cargando…

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review

SIMPLE SUMMARY: Many persons diagnosed with breast cancer are treated with endocrine therapy and will experience the side effects of endocrine therapy. Cognitive adverse effects of endocrine therapy are increasingly being recognised, and can significantly affect quality of life, adherence and treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haggstrom, Lucy R., Vardy, Janette L., Carson, Emma-Kate, Segara, Davendra, Lim, Elgene, Kiely, Belinda E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870664/ https://www.ncbi.nlm.nih.gov/pubmed/35205665 http://dx.doi.org/10.3390/cancers14040920

Ejemplares similares

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
por: Downton, Teesha, et al.
Publicado: (2022)

Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
por: Freelander, Allegra, et al.
Publicado: (2021)

Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?
por: Fardell, Joanna E, et al.
Publicado: (2023)

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
por: Portman, Neil, et al.
Publicado: (2020)

Antibody–Drug Conjugates: Ushering in a New Era of Cancer Therapy
por: Hurwitz, Joshua, et al.
Publicado: (2023)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Low dose aspirin blocks breast cancer-induced cognitive impairment in mice
por: Walker, Adam K., et al.
Publicado: (2018)

Multidisciplinary Approach to Neoadjuvant Endocrine Therapy in Breast Cancer: A Comprehensive Review
por: Reinert, Tomás, et al.
Publicado: (2016)

Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress
por: Ganz, Patricia A
Publicado: (2016)

Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review
por: Fernandes, Leonor, et al.
Publicado: (2020)

Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer
por: Vardy, Janette L, et al.
Publicado: (2018)

Epigenetic Therapies and Biomarkers in Breast Cancer
por: Brown, Lauren Julia, et al.
Publicado: (2022)

Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog)
por: Bell, M L, et al.
Publicado: (2018)

Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications
por: Selamat, Maryam Hafsah, et al.
Publicado: (2014)

A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment
por: Vardy, Janette L., et al.
Publicado: (2022)

Screening for cognitive symptoms among cancer patients during chemotherapy: Sensitivity and specificity of a single item self‐report cognitive change score
por: Fardell, Joanna E., et al.
Publicado: (2022)

Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

Renewed interest in the progesterone receptor in breast cancer
por: Lim, Elgene, et al.
Publicado: (2016)

Pre-operative Endocrine Therapy
por: Arthur, Laura M., et al.
Publicado: (2017)

Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Association between endocrine therapy and cognitive decline in breast cancer based on propensity score matching
por: Yin, Yulian, et al.
Publicado: (2023)

Does Stage at Diagnosis Affect Prognosis of Patients With Stage IV Breast, Lung, and Colorectal Cancers?
por: Kiely, Belinda E
Publicado: (2018)

Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease
por: Pinese, Mark, et al.
Publicado: (2009)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

The immunomodulatory effects of endocrine therapy in breast cancer
por: Huang, Huanhuan, et al.
Publicado: (2021)

Updates in endocrine therapy for metastatic breast cancer
por: Manohar, Poorni M., et al.
Publicado: (2022)

MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer
por: Portman, Neil, et al.
Publicado: (2021)

Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments
por: Reis, Joana, et al.
Publicado: (2020)

Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer
por: Li, Chung-Liang, et al.
Publicado: (2022)

Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones
por: Morrow, Riley J., et al.
Publicado: (2022)

Elastosis and response to endocrine therapy in human breast cancer.
por: Masters, J. R., et al.
Publicado: (1979)

A quiet revolution in the endocrine therapy of breast cancer
por: Craig Jordan, V
Publicado: (2003)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Salkeni, Mohamad Adham, et al.
Publicado: (2017)

Primary Endocrine Therapy in Older Women with Breast Cancer
por: Pepping, R. M. C., et al.
Publicado: (2017)

Preventing invasive breast cancer using endocrine therapy
por: Thorat, Mangesh A., et al.
Publicado: (2017)

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer
por: Castrellon, Aurelio Bartolome
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q3atn0mabo2ql80slakmk3hrqv